Study of DS-8201a for Participants With Advanced Solid Malignant Tumors

NCT03383692 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis

Interventions

DRUG: DS-8201a
DRUG: Ritonavir
DRUG: Itraconazole

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]